Clinical/Medical Laboratory Science/Research and Allied Professions at Albany College of Pharmacy and Health Sciences
Albany, New York • Master's
Median Earnings
$68,786
Graduates earn below the national average for this program
Earnings Comparison
This School
$68,786
Clinical/Medical Laboratory Science/Research and Allied Professions
National Average
$70,539
All schools, same program
School Average
$73,679
All programs at Albany College of Pharmacy and Health Sciences
Program Details
Master's
Credential Level
11
Completers (IPEDS)
48
Schools Offering
Debt & ROI
$68,786
Median Earnings
Clinical/Medical Laboratory Science/Research and Allied Professions at Other Schools
| School | Median Earnings | Median Debt |
|---|---|---|
| CUNY Hunter College | $98,307 | — |
| George Washington University | $85,028 | — |
| Cleveland State University | $81,303 | $58,960 |
| Rutgers University-New Brunswick | $80,212 | — |
| Long Island University | $78,462 | — |
| Drexel University | $75,151 | $87,820 |
| Albany College of Pharmacy and Health Sciences (this school) | $68,786 | — |
| Rowan University | $66,396 | $59,000 |
| The University of Texas Health Science Center at San Antonio | $66,213 | $60,954 |
| University of Alabama at Birmingham | $63,978 | $50,980 |
Other Programs at Albany College of Pharmacy and Health Sciences
| Program | Median Earnings | Median Debt |
|---|---|---|
| Pharmacy, Pharmaceutical Sciences, and Administration | $134,325 | $66,000 |
| Clinical/Medical Laboratory Science/Research and Allied Professions (current) | $68,786 | — |
| Clinical/Medical Laboratory Science/Research and Allied Professions | $63,005 | — |
| Pharmacy, Pharmaceutical Sciences, and Administration | $28,598 | $27,000 |
About the Data
Data from the U.S. Department of Education College Scorecard (2023). Earnings are median earnings for graduates after completion. Debt figures represent the median cumulative federal loan debt at graduation.
Debt-to-earnings ratio compares cumulative debt to annual earnings. A ratio below 1.0 indicates that annual earnings exceed total debt, generally considered favorable. Estimated monthly payments assume a standard 10-year repayment plan.